Top compounds associated with response to RIMKLA


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.26 1e-14
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 5e-11
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.21 7e-10
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.23 1e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 5e-09
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 4e-08
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 6e-08
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.2 6e-08
Download CSV